Pharmacokinetics of vinpocetine and apovincaminic acid in patients with impaired renal function. 1984

P Miskolczi, and L Vereczkey, and L Szalay, and C S Göndöcs

Effects of renal insufficiency on the pharmacokinetics of vinpocetine and its main metabolite, apovincaminic acid (AVA) were investigated in the present study. The elimination rate constant, half-life, clearance, area under the curve and volume of distribution were measured and compared with reported values for subjects with normal renal function. Previous investigations have shown that the elimination half life of vinpocetine was 2.54 +/- 0.48 hours and half-life of AVA was 3.66 +/- 1.56 hours in healthy volunteers after i.v. administration of 10 mg vinpocetine.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Miskolczi, and L Vereczkey, and L Szalay, and C S Göndöcs
January 1993, European journal of drug metabolism and pharmacokinetics,
P Miskolczi, and L Vereczkey, and L Szalay, and C S Göndöcs
January 1985, Journal of pharmaceutical and biomedical analysis,
P Miskolczi, and L Vereczkey, and L Szalay, and C S Göndöcs
January 1987, Polish journal of pharmacology and pharmacy,
P Miskolczi, and L Vereczkey, and L Szalay, and C S Göndöcs
September 1982, The Journal of antimicrobial chemotherapy,
P Miskolczi, and L Vereczkey, and L Szalay, and C S Göndöcs
November 1976, The Journal of infectious diseases,
P Miskolczi, and L Vereczkey, and L Szalay, and C S Göndöcs
January 1988, Drugs under experimental and clinical research,
P Miskolczi, and L Vereczkey, and L Szalay, and C S Göndöcs
April 1993, Antimicrobial agents and chemotherapy,
P Miskolczi, and L Vereczkey, and L Szalay, and C S Göndöcs
October 1986, The Japanese journal of antibiotics,
P Miskolczi, and L Vereczkey, and L Szalay, and C S Göndöcs
January 1990, Drugs,
P Miskolczi, and L Vereczkey, and L Szalay, and C S Göndöcs
January 1986, European journal of clinical pharmacology,
Copied contents to your clipboard!